228 related articles for article (PubMed ID: 16897429)
21. Prostate-Derived Ets Factor (PDEF) Inhibits Metastasis by Inducing Epithelial/Luminal Phenotype in Prostate Cancer Cells.
Wang F; Koul S; Shanmugam PST; Dong Q; Koul HK
Mol Cancer Res; 2018 Sep; 16(9):1430-1440. PubMed ID: 29848555
[TBL] [Abstract][Full Text] [Related]
22. Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter.
Chun JY; Hu Y; Pinder E; Wu J; Li F; Gao AC
Mol Cancer Ther; 2007 Sep; 6(9):2572-80. PubMed ID: 17876054
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic modifications of prostate-derived Ets transcription factor in breast cancer cells.
Sabherwal Y; Mahajan N; Zhang M
Oncol Rep; 2013 Oct; 30(4):1985-8. PubMed ID: 23921628
[TBL] [Abstract][Full Text] [Related]
24. Prostate-derived Ets factor, an oncogenic driver in breast cancer.
Sood AK; Geradts J; Young J
Tumour Biol; 2017 May; 39(5):1010428317691688. PubMed ID: 28468594
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of survivin expression by small interfering RNA suppresses proliferation of two human cancer cell lines.
Guan HT; Xue XH; Wang XJ; Li A; Qin ZY
Chin Med Sci J; 2006 Jun; 21(2):115-9. PubMed ID: 16845800
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of survivin expression by small interfering RNA induces apoptosis in human breast carcinoma cell line MCF-7.
Li JX; Zhou KY; Liang T; Zhang YF
Ai Zheng; 2005 Mar; 24(3):268-72. PubMed ID: 15757525
[TBL] [Abstract][Full Text] [Related]
27. Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression.
Sood AK; Saxena R; Groth J; Desouki MM; Cheewakriangkrai C; Rodabaugh KJ; Kasyapa CS; Geradts J
Hum Pathol; 2007 Nov; 38(11):1628-38. PubMed ID: 17521701
[TBL] [Abstract][Full Text] [Related]
28. HOXB13 regulates the prostate-derived Ets factor: implications for prostate cancer cell invasion.
Kim IJ; Kang TW; Jeong T; Kim YR; Jung C
Int J Oncol; 2014 Aug; 45(2):869-76. PubMed ID: 24898171
[TBL] [Abstract][Full Text] [Related]
29. Regulation of survivin by ErbB2 signaling: therapeutic implications for ErbB2-overexpressing breast cancers.
Xia W; Bisi J; Strum J; Liu L; Carrick K; Graham KM; Treece AL; Hardwicke MA; Dush M; Liao Q; Westlund RE; Zhao S; Bacus S; Spector NL
Cancer Res; 2006 Feb; 66(3):1640-7. PubMed ID: 16452223
[TBL] [Abstract][Full Text] [Related]
30. Novel role for PDEF in epithelial cell migration and invasion.
Gunawardane RN; Sgroi DC; Wrobel CN; Koh E; Daley GQ; Brugge JS
Cancer Res; 2005 Dec; 65(24):11572-80. PubMed ID: 16357167
[TBL] [Abstract][Full Text] [Related]
31. Prostate-derived Ets transcription factor overexpression is associated with nodal metastasis and hormone receptor positivity in invasive breast cancer.
Turcotte S; Forget MA; Beauseigle D; Nassif E; Lapointe R
Neoplasia; 2007 Oct; 9(10):788-96. PubMed ID: 17971898
[TBL] [Abstract][Full Text] [Related]
32. Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells.
Tsui KH; Lin YH; Chung LC; Chuang ST; Feng TH; Chiang KC; Chang PL; Yeh CJ; Juang HH
Cancer Lett; 2016 May; 375(1):142-151. PubMed ID: 26965996
[TBL] [Abstract][Full Text] [Related]
33. Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer.
Hou JQ; He J; Wang XL; Wen DG; Chen ZX
Chin Med J (Engl); 2006 Oct; 119(20):1734-9. PubMed ID: 17097022
[TBL] [Abstract][Full Text] [Related]
34. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen.
Ghadersohi A; Sood AK
Clin Cancer Res; 2001 Sep; 7(9):2731-8. PubMed ID: 11555586
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.
Turner DP; Findlay VJ; Moussa O; Semenchenko VI; Watson PM; LaRue AC; Desouki MM; Fraig M; Watson DK
Prostate; 2011 Dec; 71(16):1723-35. PubMed ID: 21446014
[TBL] [Abstract][Full Text] [Related]
36. Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated molecules.
Ghadersohi A; Odunsi K; Lele S; Collins Y; Greco WR; Winston J; Liang P; Sood AK
Oncol Rep; 2004 Feb; 11(2):453-8. PubMed ID: 14719083
[TBL] [Abstract][Full Text] [Related]
37. Signatures of prostate-derived Ets factor (PDEF) in cancer.
Mahajan N
Tumour Biol; 2016 Nov; 37(11):14335-14340. PubMed ID: 27612480
[TBL] [Abstract][Full Text] [Related]
38. BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells.
Promkan M; Liu G; Patmasiriwat P; Chakrabarty S
Int J Cancer; 2009 Dec; 125(12):2820-8. PubMed ID: 19551867
[TBL] [Abstract][Full Text] [Related]
39. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
Cosgrave N; Hill AD; Young LS
J Mol Endocrinol; 2006 Dec; 37(3):377-90. PubMed ID: 17170079
[TBL] [Abstract][Full Text] [Related]
40. Suppression of survivin expression by short hairpin RNA induces apoptosis in human laryngeal carcinoma cells.
Chen XM; Luan XY; Lei DP; Ma XJ; Liu XX; Liu J; Pan XL
ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):168-75. PubMed ID: 18391576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
